Li X - Search Results

1

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.

Xu T, Dong M, Wang Z, Li H, Li X. Xu T, et al. Among authors: li h, li x. Cancer Manag Res. 2020 Jul 14;12:5773-5786. doi: 10.2147/CMAR.S253349. eCollection 2020. Cancer Manag Res. 2020. PMID: 32765080 Free PMC article.

2

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways.

Zhang J, Du Y, Zhang X, Li M, Li X. Zhang J, et al. Among authors: li x, li m. J Cancer. 2018 Mar 26;9(7):1318-1328. doi: 10.7150/jca.20150. eCollection 2018. J Cancer. 2018. PMID: 29675113 Free PMC article.

3

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.

Xu T, Zhang R, Dong M, Zhang Z, Li H, Zhan C, Li X. Xu T, et al. Among authors: li h, li x. Onco Targets Ther. 2019 Dec 4;12:10639-10650. doi: 10.2147/OTT.S222967. eCollection 2019. Onco Targets Ther. 2019. PMID: 31824171 Free PMC article.

4

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis.

Li HN, Zheng WH, Du YY, Wang G, Dong ML, Yang ZF, Li XR. Li HN, et al. Oncol Lett. 2020 Mar;19(3):2163-2174. doi: 10.3892/ol.2020.11353. Epub 2020 Jan 24. Oncol Lett. 2020. PMID: 32194714 Free PMC article.

5

Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer.

Xu T, Dong M, Li H, Zhang R, Li X. Xu T, et al. Among authors: li h, li x. Oncol Lett. 2020 Jun;19(6):4053-4065. doi: 10.3892/ol.2020.11533. Epub 2020 Apr 10. Oncol Lett. 2020. PMID: 32391106 Free PMC article.

6

The Association Between Foxp3 Polymorphisms and Risk of Graves' Disease: A Systematic Review and Meta-Analysis of Observational Studies.

Li HN, Li XR, Du YY, Yang ZF, Lv ZT. Li HN, et al. Front Endocrinol (Lausanne). 2020 Jun 16;11:392. doi: 10.3389/fendo.2020.00392. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32612577 Free PMC article.

7

Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer.

Xu T, Wang Z, Dong M, Wu D, Liao S, Li X. Xu T, et al. Among authors: li x. Aging (Albany NY). 2020 Sep 11;12(17):17305-17327. doi: 10.18632/aging.103712. Epub 2020 Sep 11. Aging (Albany NY). 2020. PMID: 32915772 Free PMC article.

8

Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.

Li HN, Li XR, Lv ZT, Cai MM, Wang G, Yang ZF. Li HN, et al. Cancer Med. 2020 Dec;9(24):9554-9570. doi: 10.1002/cam4.3543. Epub 2020 Oct 14. Cancer Med. 2020. PMID: 33058542 Free PMC article.

9

TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.

Li HN, Du YY, Xu T, Zhang R, Wang G, Lv ZT, Li XR. Li HN, et al. Curr Med Sci. 2020 Dec;40(6):1137-1147. doi: 10.1007/s11596-020-2296-8. Epub 2021 Jan 11. Curr Med Sci. 2020. PMID: 33428142

10

ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer.

Zhang R, Xu T, Xia Y, Wang Z, Li X, Chen W. Zhang R, et al. Among authors: li x. Front Oncol. 2021 Feb 12;10:581733. doi: 10.3389/fonc.2020.581733. eCollection 2020. Front Oncol. 2021. PMID: 33680917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,304 results

Search Page

Filters